FL S1736

Authorizes direct-support professionals and relatives of clients in group home facilities for individuals with developmental disabilities to administer insulin, including sliding scale insulin therapy, if specified training and procedural conditions are met

Requires group home facilities to establish training programs for insulin administration, with training provided by a registered nurse, licensed practical nurse, advanced practice registered nurse, physician, or physician assistant

Mandates group home facilities adopt policies including maintaining prescribed dosage records on file, coordinating administration to avoid duplication, establishing emergency procedures, and certifying individuals who meet compliance requirements

Grants civil liability immunity to compliant group home facilities, direct-support professionals, and relatives for damages arising from insulin administration, and shields professionals and relatives from criminal penalties

Expands the authority of unlicensed direct service providers under existing medication administration law to include subcutaneous administration of insulin and epinephrine through insulin pens, epinephrine pens, or similar self-administration devices, effective July 1, 2025